Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FKK 01PD

Next Previous
Drug Profile

FKK 01PD

Alternative Names: Apomorphine prodrug - Fabre-Kramer Pharmaceuticals; FKK-01PD; TGHW 01AP

Latest Information Update: 30 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Fabre-Kramer Pharmaceuticals
  • Class Antiparkinsonians; Erectile dysfunction therapies
  • Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Erectile dysfunction; Parkinson's disease

Most Recent Events

  • 30 Nov 2023 FKK 01PD is still in preclinical development for Parkinson’s disease and Erectile Dysfunction in USA (Fabre-Kramer Pharmaceuticals pipeline, November 2023)
  • 15 Jun 2021 FKK 01PD is still in preclinical trials for Erectile-dysfunction and Parkinson's-disease in USA (PO, Capsule) (Fabre-Kramer Pharmaceuticals pipeline, June 2021)
  • 18 Jan 2017 Preclinical development is ongoing for Parkinson's disease and Erectile dysfunction in USA (Fabre Kramer website, January 2017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top